BRIEF-India's Bharat Biotech seeks to carry out Phase III Covaxin trials in Brazil

RIO DE JANEIRO, Feb 3 (Reuters) -

* INDIA'S BHARAT BIOTECH REQUESTS PERMISSION FROM BRAZIL'S HEALTH REGULATOR ANVISA TO CONDUCT PHASE III TRIALS FOR ITS COXAVIN COVID-19 VACCINE IN BRAZIL -STATEMENT

*